Vecell™ Liposomes

About Aspire Pharma

Founded in 2009, Aspire Pharmaceuticals has established itself as a leading encapsulation-focused CDMO, having produced billions of softgels for major players in the nutrition and OTC markets. The company differentiates itself by housing softgel, liquid capsule, and liposomal technology capabilities under one roof, enabling rapid and efficient development of customized product solutions. With a senior management team boasting over 100 years of collective industry experience, Aspire is positioned as a nimble innovation hub focused on enhancing product taste, texture, stability, and bioavailability.

Therapeutic Areas